Parkman Healthcare Partners LLC Rapt Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$17.99 - $40.02 $726,148 - $1.62 Million	-40,364 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.0 - $24.46 $242,992 - $371,474	15,187 Added 60.32%	40,364 $896,000
Q4 2020 Feb 12, 2021	SELL	$15.89 - $40.87 $76,796 - $197,524	-4,833 Reduced 16.1%	25,177 $497,000
Q3 2020 Nov 13, 2020	SELL	$21.6 - $37.5 $215,784 - $374,625	-9,990 Reduced 24.98%	30,010 $966,000
Q2 2020 Aug 13, 2020	BUY	$14.16 - $32.85 $566,400 - $1.31 Million	40,000 New	40,000 $1.16 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.